Related references
Note: Only part of the references are listed.Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
Tatsuhiko Fujimoto et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong et al.
NATURE COMMUNICATIONS (2021)
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor
Qiufeng Liu et al.
NATURE CHEMICAL BIOLOGY (2021)
Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivity
Jesse I. Mobbs et al.
PLOS BIOLOGY (2021)
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structural basis of Gs and Gi recognition by the human glucagon receptor
Anna Qiao et al.
SCIENCE (2020)
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim et al.
CELL (2020)
Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane
Jie Yin et al.
NATURE (2020)
Structure-based development of a subtype-selective orexin 1 receptor antagonist
Jan Hellmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes
Shoji Maeda et al.
SCIENCE (2019)
Illuminating G-Protein-Coupling Selectivity of GPCRs
Asuka Inoue et al.
CELL (2019)
Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. A. Bassetti et al.
NATURE REVIEWS NEUROLOGY (2019)
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
Dorothee Liebschner et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)
TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice
Hiroshi Yukitake et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA
Ryoji Suno et al.
STRUCTURE (2018)
Structure of the μ-opioid receptor-Gi protein complex
Antoine Koehl et al.
NATURE (2018)
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Jasenko Zivanov et al.
ELIFE (2018)
GPCR Dynamics: Structures in Motion
Naomi R. Latorraca et al.
CHEMICAL REVIEWS (2017)
Phase-plate cryo-EM structure of a class B GPCR-G-protein complex
Yi-Lynn Liang et al.
NATURE (2017)
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Shawn Q. Zheng et al.
NATURE METHODS (2017)
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani et al.
NATURE METHODS (2017)
Mini-G proteins: Novel tools for studying GPCRs in their active conformation
Rony Nehme et al.
PLOS ONE (2017)
Gctf: Real-time CTF determination and correction
Kai Zhang
JOURNAL OF STRUCTURAL BIOLOGY (2016)
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Jie Yin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Jie Yin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists
Takashi Nagahara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
CTFFIND4: Fast and accurate defocus estimation from electron micrographs
Alexis Rohou et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
Universal allosteric mechanism for Gα activation by GPCRs
Tilman Flock et al.
NATURE (2015)
Structural insights into μ-opioid receptor activation
Weijiao Huang et al.
NATURE (2015)
Orexin/hypocretin role in reward: implications for opioid and other addictions
Corey Baimel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
Jie Yin et al.
NATURE (2015)
The hypocretins/orexins: integrators of multiple physiological functions
Jingcheng Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Orexin/hypocretin receptor signalling cascades
J. P. Kukkonen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Dissecting the Hydrophobic Effect on the Molecular Level: The Role of Water, Enthalpy, and Entropy in Ligand Binding to Thermolysin
Adam Biela et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Selective orexin receptor antagonists
Terry P. Lebold et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders
Na Ye et al.
CHEMICAL REVIEWS (2013)
Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists
Da-Thao Tran et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Crystal structure of the β2 adrenergic receptor-Gs protein complex
Soren G. F. Rasmussen et al.
NATURE (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations
M. Valiev et al.
COMPUTER PHYSICS COMMUNICATIONS (2010)
Mapping the Binding Pocket of Dual Antagonist Almorexant to Human Orexin 1 and Orexin 2 Receptors: Comparison with the Selective OX1 Antagonist SB-674042 and the Selective OX2 Antagonist N-Ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA)
Pari Malherbe et al.
MOLECULAR PHARMACOLOGY (2010)
Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface Tensions
Aleksandr V. Marenich et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Circadian and dark-pulse activation of orexin/hypocretin neurons
Oliver J Marston et al.
Molecular Brain (2008)
Recent progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders
Ao Zhang et al.
CHEMICAL REVIEWS (2007)
The metabotropic glutamate receptor 4 is internalized and desensitized upon protein kinase C activation
Jesper Mosolff Mathiesen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
The Buccaneer software for automated model building.: 1.: Tracing protein chains
Kevin Cowtan
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2006)
The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions
Jamie M. Zeitzer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice:: Molecular genetic dissection of non-REM and REM sleep regulatory processes
JT Willie et al.
NEURON (2003)
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias
E Mignot et al.
ARCHIVES OF NEUROLOGY (2002)
The epidemiology of narcolepsy in Olmsted County, Minnesota: A population-based study
MH Silber et al.
SLEEP (2002)
Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
J Hara et al.
NEURON (2001)
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
C Peyron et al.
NATURE MEDICINE (2000)
Share Paper
